Amna Basheer M Ahmed1, Musa Ahmad Fagih2, Muhammed Salman Bashir3, Abdulrahman Abdullah Al-Hussaini4,5,6. 1. The Division of Pediatric Gastroenterology, Children's Specialized Hospital, King Fahad Medical City, P. O. Box 59046, Riyadh, Postal Code 11525, Kingdom of Saudi Arabia. 2. Department of Pathology and Laboratory Medicine, King Saud Medical City, Riyadh, Kingdom of Saudi Arabia. 3. Department of Biostatistics, Research Services Administration, King Fahad Medical City, Riyadh, 11525, Kingdom of Saudi Arabia. 4. The Division of Pediatric Gastroenterology, Children's Specialized Hospital, King Fahad Medical City, P. O. Box 59046, Riyadh, Postal Code 11525, Kingdom of Saudi Arabia. aa_alhussaini@yahoo.com. 5. College of Medicine, Alfaisal University, Riyadh, Kingdom of Saudi Arabia. aa_alhussaini@yahoo.com. 6. Prince Abdullah Bin Khalid Celiac Disease Research Chair, Department of Pediatrics, Faculty of Medicine, King Saud University Riyadh, Riyadh, Kingdom of Saudi Arabia. aa_alhussaini@yahoo.com.
Abstract
BACKGROUND: Investigators from different parts of the world are calling for a re-evaluation of the role of liver biopsy (LB) in the evaluation of infantile cholestasis (IC), especially in the light of emerging non-invasive diagnostic technologies. Therefore, this retrospective single-center study was conducted to determine the impact of LB on the diagnosis and management of IC in a cohort from Arabs. METHODS: From 2007 until 2019, 533 cases of IC were referred for evaluation. All infants who underwent LB were included in the study. We categorized the yield of LB into: (1) defined specific diagnosis; (2) excluded an important diagnosis. A single pathologist reviewed and made the histology report. RESULTS: 122 LB specimens met the inclusion criteria. The main indication for LB was a high suspicion of biliary atresia (BA) [high gamma-glutamyl transferase (GGT) cholestasis and pale stool] in 46 cases (37.8%). Liver biopsy had sensitivity of 86.4%, specificity (66.7%), PPV (70.4%), NPV (84.2%) in diagnosing BA. LB had a direct impact on clinical management in 52 cases (42.6%): (1) The true diagnosis was suggested by LB in 36 cases; (2) LB excluded BA and avoided intraoperative cholangiogram in 16 cases with high suspicion of BA. Among the 76 cases with low suspicion of BA, LB suggested the true diagnosis or helped to initiate specific management in 8 cases only (10.5%). In contrast, molecular testing confirmed the diagnosis in 48 (63%). CONCLUSION: LB continues to be an important tool in the workup of cases with a high suspicion of BA. The low yield of LB in cases with low suspicion of BA calls for a re-evaluation of its role in these cases in whom early incorporation of cholestasis sequencing gene panels can have a better diagnostic yield.
BACKGROUND: Investigators from different parts of the world are calling for a re-evaluation of the role of liver biopsy (LB) in the evaluation of infantile cholestasis (IC), especially in the light of emerging non-invasive diagnostic technologies. Therefore, this retrospective single-center study was conducted to determine the impact of LB on the diagnosis and management of IC in a cohort from Arabs. METHODS: From 2007 until 2019, 533 cases of IC were referred for evaluation. All infants who underwent LB were included in the study. We categorized the yield of LB into: (1) defined specific diagnosis; (2) excluded an important diagnosis. A single pathologist reviewed and made the histology report. RESULTS: 122 LB specimens met the inclusion criteria. The main indication for LB was a high suspicion of biliary atresia (BA) [high gamma-glutamyl transferase (GGT) cholestasis and pale stool] in 46 cases (37.8%). Liver biopsy had sensitivity of 86.4%, specificity (66.7%), PPV (70.4%), NPV (84.2%) in diagnosing BA. LB had a direct impact on clinical management in 52 cases (42.6%): (1) The true diagnosis was suggested by LB in 36 cases; (2) LB excluded BA and avoided intraoperative cholangiogram in 16 cases with high suspicion of BA. Among the 76 cases with low suspicion of BA, LB suggested the true diagnosis or helped to initiate specific management in 8 cases only (10.5%). In contrast, molecular testing confirmed the diagnosis in 48 (63%). CONCLUSION:LB continues to be an important tool in the workup of cases with a high suspicion of BA. The low yield of LB in cases with low suspicion of BA calls for a re-evaluation of its role in these cases in whom early incorporation of cholestasis sequencing gene panels can have a better diagnostic yield.
Entities:
Keywords:
Cholestasis; Indications; Infant; Liver biopsy; Pathology; Saudi Arabia
Authors: Cong Liu; Bruce J Aronow; Anil G Jegga; Ning Wang; Alex Miethke; Reena Mourya; Jorge A Bezerra Journal: Gastroenterology Date: 2006-10-21 Impact factor: 22.682
Authors: Pierre Russo; John C Magee; Robert A Anders; Kevin E Bove; Catherine Chung; Oscar W Cummings; Milton J Finegold; Laura S Finn; Grace E Kim; Mark A Lovell; Margret S Magid; Hector Melin-Aldana; Sarangarajan Ranganathan; Bahig M Shehata; Larry L Wang; Frances V White; Zhen Chen; Catherine Spino Journal: Am J Surg Pathol Date: 2016-12 Impact factor: 6.394
Authors: Virginia Moyer; Deborah K Freese; Peter F Whitington; Alan D Olson; Fred Brewer; Richard B Colletti; Melvin B Heyman Journal: J Pediatr Gastroenterol Nutr Date: 2004-08 Impact factor: 2.839